###begin article-title 0
###xml 132 136 <span type="species:ncbi:10090">mice</span>
Stimulation of allergen-loaded macrophages by TLR9-ligand potentiates IL-10-mediated suppression of allergic airway inflammation in mice
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 146 155 144 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 402 409 396 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 423 431 417 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
Previously, we demonstrated that OVA-loaded macrophages (OVA-Mphi) partially suppress OVA-induced airway manifestations of asthma in BALB/c mice. In vitro studies showed that OVA-Mphi start to produce IL-10 upon interaction with allergen-specific T cells, which might mediate their immunosuppressive effects. Herein, we examined whether IL-10 is essential for the immunosuppressive effects of OVA-Mphi in vivo, and whether ex vivo stimulation of the IL-10 production by OVA-Mphi could enhance these effects.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 122 130 120 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 197 205 195 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 382 386 374 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
Peritoneal Mphi were loaded with OVA and stimulated with LPS or immunostimulatory sequence oligodeoxynucleotide (ISS-ODN) in vitro. The increase of IL-10 production was examined and, subsequently, ex vivo stimulated OVA-Mphi were used to treat (i.v.) OVA-sensitized mice. To further explore whether Mphi-derived IL-10 mediates the immunosuppressive effects, Mphi isolated from IL-10-/- mice were used for treatment.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 524 527 516 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 586 593 576 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
We found that stimulation with LPS or ISS-ODN highly increased the IL-10 production by OVA-Mphi (2.5-fold and 4.5-fold increase, respectively). ISS-ODN stimulation of OVA-Mphi significantly potentiated the suppressive effects on allergic airway inflammation. Compared to sham-treatment, ISS-ODN-stimulated OVA-Mphi suppressed the airway eosinophilia by 85% (vs. 30% by unstimulated OVA-Mphi), IL-5 levels in bronchoalveolar lavage fluid by 80% (vs. 50%) and serum OVA-specific IgE levels by 60% (vs. 30%). Importantly, IL-10-/-Mphi that were loaded with OVA and stimulated with ISS-ODN ex vivo, failed to suppress OVA-induced airway inflammation.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
These results demonstrate that Mphi-derived IL-10 mediates anti-inflammatory responses in a mouse model of allergic asthma, which both can be potentiated by stimulation with ISS-ODN.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 158 160 158 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
Chronic asthma is driven and maintained by the persistence of a subset of chronically activated memory T lymphocytes. The development of allergen-specific CD4+ T-helper 2 (Th2) immunoresponses is responsible for the cellular and molecular events underlying the initiation and progression of allergic asthma [1,2]. The Th2 lymphocyte, therefore, is potentially an important target cell for therapy in allergic asthma.
###end p 11
###begin p 12
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 287 289 287 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 306 308 306 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 464 465 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 466 467 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 700 701 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 702 703 692 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 802 804 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 805 807 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 862 864 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 865 867 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 957 959 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 960 962 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1105 1106 1087 1088 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1128 1129 1107 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1130 1131 1109 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1132 1134 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
Dendritic cells (DC) are well defined as antigen presenting cells (APC) able to initiate and regulate T cell responses [3]. Besides skewing T-cell responses into Th1 or Th2 responses [4], DC have been shown to mediate the induction of antigen-specific regulatory T (Treg) cells, like CD4+ Th3 cells and CD4+ T regulatory 1 (Tr1) cells [5,6]. Macrophages (Mphi), however, can also serve as APC and play a pivotal role in controlling and directing immune responses [7,8]. To exert these functions, Mphi express MHC-II molecules and secrete a variety of mediators. By secreting pro-inflammatory cytokines, such as IL-1, IL-6 and TNF-alpha, Mphi can trigger immune responses against microbial pathogens [8,9]. Moreover, by releasing IL-12 Mphi can specifically skew immune responses towards Th1 responses [10-12]. Although Mphi favor the induction of Th1 responses [13,14], it has also been demonstrated that Mphi can induce differentiation of Th2 lymphocytes [15,16]. Similar to DC, Mphi are nowadays thought to be capable of suppressing immune responses by secreting anti-inflammatory mediators, such as PGE2, TGF-beta and IL-10 [7,9,17].
###end p 12
###begin p 13
###xml 304 305 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 306 308 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 380 389 376 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 390 392 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 393 395 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 420 429 416 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 433 441 429 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 442 444 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 605 607 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 608 610 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 812 814 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 831 833 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 847 849 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 850 852 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
In the lung, alveolar Mphi participate in the maintenance of immunological homeostasis. By secreting pro-inflammatory cytokines and chemokines they direct the recruitment and activation of inflammatory cells, while they also play a key role in dampening immune responses against non-pathogenic antigens [9,18]. Alveolar Mphi have been shown to suppress T-lymphocyte proliferation in vitro [19,20] and APC-function of DC in vitro and in vivo [21]. Additionally, several studies have demonstrated that Mphi induce tolerance against inhaled allergens, likely at the level of allergen-specific T lymphocytes [22-24]. Interestingly, selective elimination of alveolar Mphi potentiated IgE Ab production in response to inhaled allergen, indicating a key role for alveolar Mphi in tolerance against allergen inhalation [25]. Moreover, we [26] and others [12,27] demonstrated that treatment with allergen-loaded Mphi effectively suppresses allergen-induced airway manifestations of asthma.
###end p 13
###begin p 14
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 203 205 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 304 306 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 387 389 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 552 556 542 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
In vitro studies demonstrated that allergen-specific T cells induced IL-10 production by OVA-loaded Mphi (OVA-Mphi), suggesting that the immunosuppressive effects of OVA-Mphi might be mediated by IL-10 [26]. In this study, we investigated whether stimulation with toll like receptor 4 (TLR4)-ligand LPS [28] and the TLR9-ligand immunostimulatory sequence oligodeoxynucleotide (ISS-ODN) [29] increases the IL-10 production by allergen-loaded Mphi and, thereby, can potentiate their immunosuppressive effects. Subsequently, using Mphi isolated from IL-10-/- mice, we examined whether Mphi-derived IL-10 is crucial in the suppression of allergen-induced allergic airway inflammation.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Animals
###end title 16
###begin p 17
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 405 409 405 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 560 570 560 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
Animal care and use were performed in accordance with the guidelines of the Dutch Committee of Animal Experiments. Specific pathogen-free (according to the Federation of European Laboratory Animal Science Associations [30]) male BALB/c mice (6 wk old) were purchased from Charles River (Maastricht, The Netherlands). The mice were housed in macrolon cages in a laminar flow cabinet. Breeding pairs of IL10-/- BALB/c mice were kindly provided by DNAX (Palo Alto, CA) and were housed in macrolon cages with filter top. All mice were provided with food and water ad libitum.
###end p 17
###begin title 18
Materials
###end title 18
###begin p 19
###xml 57 74 57 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 5 12 <span type="species:ncbi:9031">chicken</span>
###xml 57 73 <span type="species:ncbi:562">Escherichia coli</span>
OVA (chicken egg albumin, grade V) and purified LPS from Escherichia coli 0111:B4 were purchased from Sigma-Aldrich (St. Louis, MO). CpG-containing phosphorothioate ISS-ODN and control phosphorothioate mutated oligodeoxynucleotide were synthesized by Isogen Bioscience BV (Maarsen, The Netherlands). The ISS-ODN used had the sequence 5'-TGACTGTGAA-CGTTCGAGATGA-3' and the mutated-ODN had the sequence 5'-TGACTGTGAA-GGTTAGAGATGA-3' [31].
###end p 19
###begin title 20
Loading and stimulation of Mphi
###end title 20
###begin p 21
###xml 78 80 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 87 96 85 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 236 238 232 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 515 516 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Peritoneal Mphi were isolated from naive BALB/c mice as described previously [26]. For in vitro experiments, Mphi were plated in triplicate wells of a 96-well round-bottomed plate (Greiner Bio-One GmbH, Kremsmuenster, Austria) at 1 x 105 Mphi/well in RPMI 1640 enriched with 2% FCS, penicillin/streptomycin (all GIBCO BRL) and 50 muM beta-mercaptoethanol (Sigma-Aldrich). Mphi were loaded with 2 mg/mL OVA and stimulated with different concentrations of LPS, ISS-ODN or mutated-ODN, for 20 h at 37degreesC and 5% CO2. Subsequently, supernatants were harvested and the amount of IL-10 was determined using an IL-10-specific sandwich ELISA. Stimulation with 10 mug/mL LPS or 3 mug/mL ISS-ODN triggered the highest IL-10 production by Mphi.
###end p 21
###begin p 22
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 174 175 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
For in vivo studies, 1 x 107 Mphi/mL were loaded with 2 mg/mL OVA and were stimulated with 10 mug/mL LPS or 3 mug/mL ISS-ODN. After incubation for 3 h at 37degreesC and 5% CO2, the Mphi were extensively washed (3 times with 50 mL saline) to remove all residual soluble OVA, LPS, and ISS-ODN.
###end p 22
###begin title 23
Sensitization, treatment and challenge
###end title 23
###begin p 24
###xml 138 140 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 238 240 237 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
Mice were sensitized to OVA by active sensitization with 7 i.p. injections of 10 mug OVA in 0.5 mL pyrogen-free saline on alternate days [32]. Treatment was performed 17 days after the last sensitization by administration (i.v.) of 3 x 105 Mphi in 50 mul saline. As an additional control group, mice were i.v. injected with 50 muL saline (sham treatment). One week after treatment, mice were exposed to OVA (2 mg/mL saline) aerosol challenges for 5 min on 8 consecutive days.
###end p 24
###begin title 25
Determination of OVA-specific IgE levels in serum
###end title 25
###begin p 26
###xml 185 187 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
Mice were sacrificed and were bled by cardiac puncture. Subsequently, serum was collected and stored at -70degreesC until analysis. OVA-specific IgE in serum was measured as described [33]. A reference standard was obtained by i.p. immunization of mice with OVA and arbitrarily assigned a value of 1000 experimental units/mL (EU/mL). The detection level of the IgE ELISA was 0.5 U/mL for IgE.
###end p 26
###begin title 27
Analysis of the cellular composition in the bronchoalveolar lavage fluid
###end title 27
###begin p 28
###xml 610 612 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
Bronchoalveolar lavage (BAL) was performed immediately after bleeding of the mice by lavage of the airways through a tracheal cannula with 1 mL saline containing 2 mug/mL aprotinine (Roche Diagnostics) and 5% BSA (Sigma-Aldrich). Cytokines in the supernatant of this first mL of the BAL fluid (BALF) were determined by ELISA. Subsequently, mice were lavaged 4 times with 1 mL saline. The cells in the BALF were pooled in cold PBS (including those from the first mL) and subsequently differentiated into mononuclear cells (monocytes, Mphi and lymphocytes), eosinophils, and neutrophils as described previously [33].
###end p 28
###begin title 29
Cytokine ELISAs
###end title 29
###begin p 30
IL-5, IL-10, IL-12p70 ELISAs (all BD PharMingen) were performed according to the manufacturer's instructions. The detection limit of the IL-5 ELISA was 10 pg/mL, of the IL-10 ELISA 15 pg/mL, and of the IL-12p70 ELISA 62.5 pg/mL.
###end p 30
###begin title 31
Statistical analysis
###end title 31
###begin p 32
###xml 158 160 156 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U </italic>
###xml 240 242 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 331 333 329 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
All data are expressed as mean +/- standard error of mean (SEM). Statistical analysis on BALF cell counts was performed using the non-parametric Mann-Whitney U test (2-tailed). For ELISA, results were statistical analyzed using a Student's t test (2-tailed, homoscedastic). Results were considered statistically significant at the P < .05 level.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
IL-10 production by Mphi is increased by LPS and ISS-ODN
###end title 34
###begin p 35
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 113 115 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 263 265 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 266 268 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 423 424 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 514 522 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
In vitro studies suggest that the immunosuppressive effects of OVA-Mphi could be mediated by Mphi-derived IL-10 [26]. To further enhance these immunosuppressive effects we attempted to increase the IL-10 levels produced by Mphi. Since Mphi express TLR4 and TLR9 [28,29], we tested whether activation of these receptors (using LPS and ISS-ODN, respectively) would increase the IL-10 production by peritoneal Mphi. As Figure 1 shows, stimulation with LPS or ISS-ODN highly increased the IL-10 production by OVA-Mphi in vitro, while control mutated oligodeoxynucleotide did not. The IL-10 levels produced by OVA-Mphi increased 2.5-fold upon stimulation with LPS and 4.5-fold upon stimulation with ISS-ODN. IL-12p70 was not detectable in any of these cultures (data not shown).
###end p 35
###begin p 36
###xml 114 115 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
LPS and immunostimulatory sequence oligodeoxynucleotide (ISS-ODN) enhance the IL-10 production by OVA-Mphi. 1 x 105 Mphi/well were loaded with 2 mg/ml OVA and stimulated with either 10 mug/ml LPS or 3 mug/ml ISS-ODN for 20 h. As a control, Mphi were stimulated with mutated-ODN (M-ODN, 3 mug/ml). One of four representative experiments is shown.
###end p 36
###begin title 37
Increased production of IL-10 potentiates the suppressive effects of OVA-Mphi
###end title 37
###begin p 38
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
To examine the in vivo effect of the increased production of IL-10 by OVA-Mphi, peritoneal Mphi were isolated and subsequently loaded with OVA and stimulated with LPS (10 mug/mL) or ISS-ODN (3 mug/mL) for 3 h. The stimulated and OVA-loaded Mphi were administered (i.v.) to OVA-sensitized mice.
###end p 38
###begin p 39
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 268 269 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 344 346 340 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 405 406 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
In sham-treated mice, OVA-inhalation challenge strongly increased OVA-specific IgE Ab in serum (Figure 2). Treatment with OVA-Mphi that were not stimulated or stimulated with LPS caused no significant suppression in the up-regulation of serum OVA-specific IgE (Figure 2). In contrast, ISS-ODN-stimulated OVA-Mphi significantly suppressed (60%, P < .05) the up-regulation of serum OVA-specific IgE (Figure 2). OVA-specific IgG2a levels in serum of sham-treated mice were also increased upon OVA-inhalation challenge. However, these levels were not affected upon treatment with OVA-Mphi or stimulated OVA-Mphi (data not shown).
###end p 39
###begin p 40
###xml 480 482 466 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 540 546 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
###xml 546 548 527 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
OVA-specific IgE levels in serum are significantly suppressed upon treatment with ISS-ODN-stimulated and OVA-loaded Mphi. OVA-sensitized BALB/c mice were treated (i.v.) with saline (sham), OVA-Mphi, ISS-ODN-stimulated OVA-Mphi (ISS-ODN/OVA-Mphi), or LPS-stimulated OVA-Mphi (LPS/OVA-Mphi). Subsequently, these mice were challenged by OVA inhalation. Serum OVA-specific IgE levels were measured prior to and after challenge. Values are expressed as the mean +/- SEM (n = 6 to 8). *P < .05 compared with sham-treated and OVA-challenged mice. daggerP < .05 compared with mice treated with OVA-Mphi and that were OVA-challenged.
###end p 40
###begin p 41
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 199 207 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ex vivo </italic>
###xml 302 304 298 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 352 354 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 496 498 490 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 611 613 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
The BALF of mice, sensitized and challenged with OVA, contained high numbers of eosinophils (Figure 3A). OVA-Mphi partially suppressed (30%, not significant) the influx of eosinophils into the BALF. Ex vivo stimulation of OVA-Mphi with LPS further enhanced the suppression of airway eosinophilia (60%, P < .05), compared with sham-treated mice (Figure 3A). OVA-Mphi stimulated with ISS-ODN effectively suppressed the airway eosinophilia. The number of eosinophils in the BALF were significantly (P < .01) suppressed by 85% compared to sham-treated mice and by 79% compared to mice treated with OVA-Mphi (Figure 3A).
###end p 41
###begin p 42
###xml 372 374 366 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 384 390 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
###xml 390 392 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 431 444 420 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8225;</sup>
###xml 444 446 421 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 456 468 433 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#167;</sup>
###xml 468 470 434 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
ISS-ODN-stimulated and OVA-loaded Mphi (ISS-ODN/OVA-Mphi) significantly suppress airway eosinophilia and IL-5 levels in the bronchoalveolar lavage fluid. The number of eosinophils (eo), neutrophils (neutro) and mononuclear cells (MNC) in the BALF (A), and IL-5 levels in the BALF (B) after OVA inhalation challenge. Values are expressed as the mean +/- SEM (n = 6 to 8). *P < .01 and daggerP < .05 compared with sham-treated mice. double daggerP < .01 and section signP < .05 compared with mice treated with OVA-Mphi.
###end p 42
###begin p 43
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 310 312 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 367 369 361 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
The BALF of sham-treated mice contained high levels of the Th2 cytokine IL-5 (Figure 3B), that correlates with the numbers of eosinophils. Treatment with OVA-Mphi or LPS-stimulated OVA-Mphi reduced the IL-5 levels in the BALF by 50% (p = 0.07 and p = 0.06, respectively), compared to sham-treated mice (Figure 3B). ISS-ODN-stimulated OVA-Mphi, significantly reduced (P < .01) the IL-5 levels in the BALF by 80%, compared to sham-treated mice. IL-10 was not detectable in the BALF of any of the mice (data not shown).
###end p 43
###begin p 44
Since ISS-ODN-stimulated OVA-Mphi produced the highest levels of IL-10 and most strongly suppressed OVA-induced airway inflammation, we used these Mphi to further analyze the underlying mechanism of immunosuppression by allergen-loaded Mphi.
###end p 44
###begin title 45
IL-10 produced by OVA-Mphi suppress OVA-induced airway inflammation
###end title 45
###begin p 46
###xml 135 139 131 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 204 211 200 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 222 226 218 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
To prove that IL-10 produced by OVA-Mphi indeed mediates the observed immunosuppressive effects, we isolated peritoneal Mphi from IL-10-/- BALB/c mice. After loading with OVA and stimulation with ISS-ODN ex vivo, the IL-10-/- Mphi were administered (i.v.) to OVA-sensitized BALB/c mice.
###end p 46
###begin p 47
###xml 94 98 94 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 153 154 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 267 271 265 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 288 289 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 407 411 403 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 458 460 452 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
Serum OVA-specific IgE levels of allergic mice that were treated with ISS-ODN-stimulated IL-10-/- Mphi were as high as that of sham-treated mice (Figure 4). However, the up-regulation of serum OVA-specific IgE levels was partially affected by ISS-ODN-stimulated IL-10-/- OVA-Mphi (Figure 4). The serum OVA-specific IgE levels were approximately 50% suppressed compared with unloaded ISS-ODN-stimulated IL-10-/- Mphi. Still, these IgE levels were 45% higher (P < .05) than in mice treated with ISS-ODN-stimulated OVA-Mphi.
###end p 47
###begin p 48
###xml 247 251 241 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 269 272 261 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 306 310 296 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 332 335 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 490 492 474 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 550 556 534 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
###xml 556 558 535 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 608 611 587 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
The suppression of OVA-specific IgE in serum by ISS-ODN-stimulated and OVA-loaded Mphi is partially mediated by IL-10. Sensitized mice were treated (i.v.) with saline (sham), ISS-ODN-stimulated OVA-Mphi (ISS-ODN/OVA-Mphi), ISS-ODN-stimulated IL-10-/- Mphi (ISS-ODN/IL10-/-Mphi), or ISS-ODN-stimulated IL-10-/- OVA-Mphi (ISS-ODN/IL10-/-OVA-Mphi). Serum OVA-specific IgE levels were measured prior to and after OVA challenge. Values are expressed as the mean +/- SEM (n = 6 to 8 per group). *P < .05 compared with sham-treated and OVA-challenged mice. daggerP < .05 compared with mice treated with ISS-ODN/IL10-/-OVA-Mphi and that were OVA-challenged.
###end p 48
###begin p 49
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 142 144 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 161 165 159 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 345 347 339 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 393 395 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
Importantly, after OVA-inhalation challenge, treatment with ISS-ODN-stimulated IL-10-/- OVA-Mphi did not suppress airway eosinophilia (Figure 5A). Unloaded IL-10-/- Mphi that were stimulated with ISS-ODN had also no effect on airway eosinophilia, while immunotherapy with ISS-ODN-stimulated OVA-Mphi suppressed the influx of eosinophils by 88% (P < .05), compared to sham-treated mice (Figure 5A).
###end p 49
###begin p 50
###xml 405 407 399 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 446 452 440 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
###xml 452 454 441 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 504 507 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
IL-10 is crucial in the suppression of airway eosinophilia and IL-5 levels in the bronchoalveolar lavage fluid by ISS-ODN-stimulated and OVA-loaded Mphi (ISS-ODN/OVA-Mphi). (A) Number of eosinophils (eo), neutrophils (neutro) and mononuclear cells (MNC) in the BALF after OVA challenge. (B) Levels of IL-5 in the BALF after OVA challenge. Values are expressed as the mean +/- SEM (n = 6 to 8 per group). *P < .05 compared with sham-treated mice. daggerP < .05 compared with mice treated with ISS-ODN/IL10-/-OVA-Mphi.
###end p 50
###begin p 51
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 202 206 200 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 264 266 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 335 337 331 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 400 402 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
The BALF of sham-treated mice, sensitized and challenged with OVA, contained high levels of IL-5 (Figure 5B). Treatment with ISS-ODN-stimulated IL-10-/- OVA-Mphi as well as with ISS-ODN-stimulated IL-10-/- Mphi had no effect on the IL-5 levels in the BALF (Figure 5B). In contrast, these IL-5 levels were significantly reduced by 78% (P < .05) upon treatment with ISS-ODN-stimulated OVA-Mphi (Figure 5B).
###end p 51
###begin p 52
Together, IL-10 produced by OVA-Mphi mediated the anti-inflammatory effects of allergen-loaded Mphi on allergen-induced airway eosinophilia and IL-5 production.
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 115 117 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Previously, we showed that allergen-loaded Mphi partially suppress allergen-induced airway manifestations in mice [26]. Here, we demonstrated that the anti-inflammatory effects of allergen-loaded Mphi are IL-10 dependent and that both the IL-10 production and the immunosuppressive effects can be potentiated by stimulation of ISS-ODN.
###end p 54
###begin p 55
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 224 226 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 796 798 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1230 1232 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 296 301 <span type="species:ncbi:10090">mouse</span>
Stimulation with ISS-ODN, a ligand for TLR9 [29], readily increased the IL-10-production by peritoneal Mphi that were loaded with OVA. In contrast, these Mphi produced no detectable IL-12p70. We (data not shown) and others [34] confirmed these data using the Mphi-like cell line RAW264.7. In our mouse model of allergic asthma, stimulation of OVA-Mphi with ISS-ODN significantly potentiated their immunosuppressive effects. The suppression of the OVA-induced serum OVA-specific IgE levels, airway eosinophilia and IL-5 levels in the BALF was enhanced. Measuring the enhanced pause (Penh) in response to inhalation of different doses of methacholine (data not shown), we confirmed our previous finding that OVA-Mphi significantly suppressed OVA-induced airway hyperresponsiveness to methacholine [26]. As potentiation of the IL-10 production by Mphi (using LPS or ISS-ODN) did not further suppress the allergen-induced airway hyperresponsiveness (data not shown), it can be speculated that the mechanisms underlying the suppression of airway hyperresponsiveness and of allergic airway inflammation, at least in part, differ. However, we would like to stress that Penh values may not correlate with changes in pulmonary resistance [35].
###end p 55
###begin p 56
###xml 453 455 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
Compared to ISS-ODN, stimulation with LPS showed an intermediate capacity to enhance the immunosuppressive effects of OVA-Mphi. OVA-Mphi produced higher levels of IL-10 upon stimulation with ISS-ODN compared to stimulation with LPS, suggesting a correlation between the levels of IL-10 produced by the Mphi and the extent of suppression of allergen-induced airway inflammation. As LPS and ISS-ODN trigger signaling via different intracellular pathways [36], we hypothesized that stimulation of Mphi with a combination of LPS and ISS-ODN could further increase the production of IL-10. However, the levels of IL-10 produced by OVA-Mphi stimulated with LPS and ISS-ODN were as high as when stimulated with ISS-ODN only (data not shown). Implying that stimulation of Mphi with ISS-ODN results in maximal production of IL-10.
###end p 56
###begin p 57
###xml 30 34 28 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 339 343 333 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 412 414 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 415 417 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1151 1153 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
Using Mphi isolated from IL-10-/- BALB/c mice, we demonstrated that Mphi-derived IL-10 is crucial in the suppression of airway eosinophilia and IL-5 levels in the BALF, while the suppression of serum IgE is partially IL-10 dependent. Although a lack of IL-10 production could up-regulate the MHC class II and B7 expression in Mphi of IL-10-/- mice, as increased IL-10 levels could down-regulate these molecules [37,38], the shift in expression of these molecules will most probably not be the underlying mechanism of suppression of airway eosinophilia and Th2 cytokines, because low levels of MHC class II or B7 itself do not result in suppressive functions. Furthermore, we can not exclude that there are, at present unknown, developmental changes in Mphi derived from IL-10-deficient mice, that may affect their capacity to suppress an allergic inflammatory response. The observation that the suppression of IgE is partially IL-10 independent suggests that the suppression of serum IgE levels is only slightly correlated to Th2-cytokine levels. This is in agreement with the finding that memory IgE responses are inferior mediated by Th2 cytokines [39]. These data indicate that a second, IL-10 independent, suppressive pathway has to be induced by OVA-Mphi that causes a further suppression of serum IgE levels.
###end p 57
###begin p 58
###xml 71 73 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 322 324 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 325 327 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 966 974 956 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1022 1024 1012 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 315 320 <span type="species:ncbi:10090">mouse</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
Mphi can reside for long period of time in tissue, including the lung [40]. By secreting the immunosuppressive cytokine IL-10 the Mphi could, allergen-independently, suppress allergen-induced airway inflammation. In the past, IL-10 has been shown to suppress allergen-induced airway manifestations of asthma in the mouse [41-43]. However, we found that, after i.v. treatment, the ISS-ODN-stimulated OVA-Mphi specifically migrate to the spleen of OVA-sensitized mice. Subsequently, at this site, an allergen-specific and long-lasting immunosuppressive response is induced (preliminary results by Vissers JLM et al). These results demonstrate that the IL-10 produced by the Mphi is not directly responsible for the suppression of allergic inflammation in the lungs, but that an allergen-specific suppressive T-cell subset is induced in the spleen. This hypothesis is supported by the finding that IL-10 production by OVA-Mphi, upon recognition of OVA-specific T cells in vitro, is dependent on MHC class II/TCR interaction [26].
###end p 58
###begin p 59
###xml 261 263 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 665 667 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 668 670 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 468 473 <span type="species:ncbi:10090">mouse</span>
###xml 585 591 <span type="species:ncbi:9606">humans</span>
###xml 620 628 <span type="species:ncbi:9606">patients</span>
Direct targeting of OVA to alveolar Mphi, for instance by intratracheal treatment with OVA-loaded liposomes, could demonstrate whether Mphi in the lung can directly induce suppression of OVA-induced airway inflammation. However, we (data not shown) and others [44] found that alveolar Mphi from OVA-sensitized mice do not produce IL-10 upon stimulation with LPS or ISS-ODN. Although we were not able to test the suppressive capacity of OVA-loaded alveolar Mphi in our mouse model, targeting of allergens to alveolar Mphi could still be promising to induce immunosuppressive effects in humans, because alveolar Mphi from patients with allergic asthma produce IL-10 [45,46].
###end p 59
###begin p 60
###xml 41 43 41 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 262 269 254 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 317 319 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 320 322 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 525 527 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 585 587 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 636 637 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 638 640 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 923 924 903 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1153 1155 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1170 1172 1147 1149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1187 1195 1164 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 1349 1351 1326 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1531 1532 1508 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1533 1535 1510 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1581 1602 1558 1579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium vaccae </italic>
###xml 1673 1675 1647 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
###xml 1564 1568 <span type="species:ncbi:10090">mice</span>
###xml 1581 1601 <span type="species:ncbi:1810">Mycobacterium vaccae</span>
In this study and in our previous study [26], we observed no indications for an increased Th1 response upon immunotherapy with OVA-Mphi that could counteract the Th2 response. In contrast, others demonstrated that allergen-loaded Mphi, stimulated with IFN-gamma ex vivo, promote a switch from Th2 cells to Th1 cells [12,27]. This dissimilarity can mainly be explained by the difference in cytokines which are produced by the Mphi used. IFN-gamma-stimulated Mphi produce IL-12 upon allergen-specific interaction with T cells [12], while our Mphi produce IL-10 upon antigen recognition [26]. Likely, IL-12 will favor skewing towards Th1 [4,11], whereas IL-10 will act as a suppressive cytokine. In our model, allergen-loaded Mphi will, most probably, induce Treg cells via secretion of IL-10. Antigen-induced Treg cells are typically induced in microenvironments with APCs presenting antigens and local high levels of IL-10 [6]. This T-cell subset plays a pivotal role in the maintenance of T-cell tolerance against foreign-antigens. They exhibit their suppressive activity by secreting the suppressive cytokine IL-10 (Tr1 cells) or TGF-beta (Th3 cells) [47]. By using CD4+ T lymphocytes, ex vivo transduced to express IL-10, it was shown that allergen-specific lymphocytes can suppress allergen-induced asthma manifestations via production of IL-10 [43]. Recently, Akbari and colleagues found that pulmonary dendritic cells from mice exposed to respiratory allergen produced IL-10 and, thereby, induced allergen-specific Tr1 cells [5,48]. Furthermore, treatment of mice with killed Mycobacterium vaccae induced allergen-specific Treg cells that produced IL-10 and TGF-beta [49]. In agreement with our study, these studies indicate a pivotal role for IL-10 in limiting allergen-induced asthma manifestations.
###end p 60
###begin title 61
Conclusions
###end title 61
###begin p 62
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Here, we demonstrated, in a mouse model of allergic airway inflammation, that treatment with allergen-loaded Mphi suppress asthma manifestations in an IL-10-dependent manner. Importantly, the IL-10 production and anti-inflammatory effects of allergen-loaded Mphi can be potentiated by stimulation with ISS-ODN. Further detailed analysis of the mechanisms underlying this Mphi-based immunotherapy may lead to the development of new strategies to induce tolerance against allergen-specific Th2 responses in allergic diseases, including asthma.
###end p 62
###begin title 63
Authors' contributions
###end title 63
###begin p 64
JLMV carried out the allergic model, subsequent analysis, writing and preparation of the manuscript. BCAMvE, PVJ and GAH assisted with the allergic model. AJMvO participated in the direction of the study as well as writing and preparing the manuscript. All authors read and approved the final manuscript.
###end p 64
###begin title 65
Acknowledgments
###end title 65
###begin p 66
###xml 233 237 233 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
This study was supported by research grants 3.2.00.48 (JLMV) and 3.2.99.23 (PVJ) from The Dutch Asthma Foundation and by Stichting Astma Bestrijding (BCAMvE). We thank Dr. D. Rennick (DNAX) for providing us the breeding pairs of IL10-/- BALB/c mice. We thank Dr. Nanne Bloksma for stimulating discussions and Dr. Sue McKay for critical reading of the manuscript.
###end p 66
###begin article-title 67
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology
###end article-title 67
###begin article-title 68
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
###end article-title 68
###begin article-title 69
Dendritic cells and the control of immunity
###end article-title 69
###begin article-title 70
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype
###end article-title 70
###begin article-title 71
Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen
###end article-title 71
###begin article-title 72
The mucosal milieu creates tolerogenic dendritic cells and TR1 and TH3 regulatory cells
###end article-title 72
###begin article-title 73
Other functions, other genes: alternative activation of antigen-presenting cells
###end article-title 73
###begin article-title 74
Alternative activation of macrophages
###end article-title 74
###begin article-title 75
Functional heterogeneity in liver and lung macrophages
###end article-title 75
###begin article-title 76
Macrophages and polymorphonuclear neutrophils in lung defense and injury
###end article-title 76
###begin article-title 77
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages
###end article-title 77
###begin article-title 78
Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses
###end article-title 78
###begin article-title 79
The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies
###end article-title 79
###begin article-title 80
Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism
###end article-title 80
###begin article-title 81
Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns
###end article-title 81
###begin article-title 82
M-1/M-2 macrophages and the Th1/Th2 paradigm
###end article-title 82
###begin article-title 83
The role of prostaglandin E2 in immune suppression following injury
###end article-title 83
###begin article-title 84
The role of alveolar macrophages in regulation of lung inflammation
###end article-title 84
###begin article-title 85
Regulation of T-cell function in lung tissue by pulmonary alveolar macrophages
###end article-title 85
###begin article-title 86
###xml 26 32 <span type="species:ncbi:9606">humans</span>
Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion
###end article-title 86
###begin article-title 87
Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages
###end article-title 87
###begin article-title 88
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen
###end article-title 88
###begin article-title 89
The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production
###end article-title 89
###begin article-title 90
###xml 167 173 <span type="species:ncbi:10090">murine</span>
Aerosol-induced immunoglobulin (Ig)-E unresponsiveness to ovalbumin does not require CD8+ or T cell receptor (TCR)-gamma/delta+ T cells or interferon (IFN)-gamma in a murine model of allergen sensitization
###end article-title 90
###begin article-title 91
Regulation of IgE production in pre-sensitized animals: in vivo elimination of alveolar macrophages preferentially increases IgE responses to inhaled allergen
###end article-title 91
###begin article-title 92
###xml 60 66 <span type="species:ncbi:10090">murine</span>
Immunomodulatory effects of antigen-pulsed macrophages in a murine model of allergic asthma
###end article-title 92
###begin article-title 93
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Antigen presentation by local macrophages promotes nonallergic airway responses in sensitized mice
###end article-title 93
###begin article-title 94
Toll-like receptors and innate immunity
###end article-title 94
###begin article-title 95
Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity
###end article-title 95
###begin article-title 96
###xml 56 62 <span type="species:ncbi:9986">rabbit</span>
Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units
###end article-title 96
###begin article-title 97
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
###end article-title 97
###begin article-title 98
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice
###end article-title 98
###begin article-title 99
###xml 138 144 <span type="species:ncbi:10090">murine</span>
Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma
###end article-title 99
###begin article-title 100
Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response
###end article-title 100
###begin article-title 101
The use and misuse of Penh in animal models of lung disease
###end article-title 101
###begin article-title 102
Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments
###end article-title 102
###begin article-title 103
###xml 54 59 <span type="species:ncbi:9606">human</span>
Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes
###end article-title 103
###begin article-title 104
IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
###end article-title 104
###begin article-title 105
Secondary IgE responses in vivo are predominantly generated via gamma 1 epsilon-double positive B cells
###end article-title 105
###begin article-title 106
Macrophages in tissues and in vitro
###end article-title 106
###begin article-title 107
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice
###end article-title 107
###begin article-title 108
IL-10 induces a Th2 cell tolerance in allergic asthma
###end article-title 108
###begin article-title 109
CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation
###end article-title 109
###begin article-title 110
###xml 27 33 <span type="species:ncbi:10090">murine</span>
Lack of IL-10 synthesis by murine alveolar macrophages upon lipopolysaccharide exposure: Comparison with peritoneal macrophages
###end article-title 110
###begin article-title 111
###xml 79 84 <span type="species:ncbi:9606">human</span>
Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors
###end article-title 111
###begin article-title 112
Low-dose theophylline does not exert its anti-inflammatory effects in mild asthma through upregulation of interleukin-10 in alveolar macrophages
###end article-title 112
###begin article-title 113
Regulatory T cells in the control of immune pathology
###end article-title 113
###begin article-title 114
Antigen-specific regulatory T cells develop via the ICOS ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity
###end article-title 114
###begin article-title 115
###xml 45 65 <span type="species:ncbi:1810">Mycobacterium vaccae</span>
Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells
###end article-title 115

